About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Philadelphia | 189 Studies

Clinical Trials COPDPhiladelphia

COPD Clinical Trials in Philadelphia

Find 189 clinical trials for copd near Philadelphia, Pennsylvania. Connect with research centers in your area.

All COPD trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 189 trials

CompletedClinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe EmphysemaThis trial is for men and women between the ages of 40 and 74 who have a confirmed diagnosis of emphysema.NCT00475007·Birmingham, Alabama and 33 others

COPD Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedRoflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)To demonstrate the additional benefit of roflumilast when added on to fixed-dose combination (FDC) LABA/ICS in the reduction of exacerbations in subjects with severe to very…NCT01443845·Anniston, Alabama and 337 others

UnknownClinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic BronchitisThis is a prospective, randomized, parallel group, double-blind, sham-controlled, multicenter clinical trial following patients to 2 years.NCT04677465·Birmingham, Alabama and 36 others

UnknownStudy of Ambulatory Respiratory Assist Device in Chronic Obstructive Pulmonary Disease PatientsThe study is a two-part small scale, open-label, pilot study to evaluate feasibility and proof-of-concept for a respiratory assist medical device.NCT03531489·Philadelphia, Pennsylvania

CompletedA Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)This study evaluated the effect of inhaled aclidinium bromide on exercise endurance and in reducing resting and dynamic lung hyperinflation in patients with moderate to severe…NCT00500318·Jasper, Alabama and 51 others

CompletedA Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD PatientsThis is a Phase 2a, proof-of-concept, multicenter, randomized, double-blind, double dummy, 3-treatment, parallel study, with low and high YPL 001 doses (low dose and high dose…NCT02272634·Birmingham, Alabama and 3 others

CompletedEfficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent ExacerbationsPhase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated…NCT04053634·Surprise, Arizona and 342 others

CompletedEfficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPDTo evaluate the efficacy and safety of arformoterol tartrate inhalation solution 30μg/4mL QD (two 15μg/2mL dosed in combination) over a 24-hour period compared to arformoterol…NCT00571428·Medford, Oregon and 3 others

CompletedEffect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)The aim of the study is to compare the effect of roflumilast on exacerbation rate and pulmonary function in patients with chronic obstructive pulmonary disease (COPD).NCT00297115·Bayou La Batre, Alabama and 286 others

CompletedPennsylvania Study Of Chronic Obstructive Pulmonary ExacerbationsThe overall purpose of PA-SCOPE is to determine why black and rural residents of Pennsylvania might be at higher risk for deadly, debilitating, and costly hospitalizations for…NCT00774176·Lancaster, Pennsylvania and 2 others

RecruitingA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseThis Phase IIb dose-ranging study will evaluate the efficacy and safety of 2 different doses of AZD6793 compared with placebo tablets in participants with moderate to very severe…NCT07082738·Birmingham, Alabama and 366 others

RecruitingEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypeThis is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in…NCT07190209·Chandler, Arizona and 313 others

TerminatedADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.This study evaluates the effect of two medicines on COPD (Chronic Obstructive Pulmonary Disease). The study will last 12 weeks.NCT00346749·Birmingham, Alabama and 10 others

CompletedCo-administration of Olodaterol Respimat® and Tiotropium Handihaler®The overall objective of this study is to assess efficacy and safety of 12 weeks, once daily, orally inhaled co-administration of olodaterol 5 µg (delivered by the Respimat®…NCT01696058·Anniston, Alabama and 93 others

Active not recruitingStudy of COPD Subgroups and BiomarkersSPIROMICS I, SPIROMICS II, and SPIROMICS III are longitudinal observational studies of Chronic Obstructive Pulmonary Disease (COPD) cohort.NCT01969344·Birmingham, Alabama and 13 others

CompletedPilot Study of the Spiration IBV™ SystemThe Spiration Intra-Bronchial Valve is intended for use as a minimally invasive treatment for severe emphysema, using standard bronchoscopy.NCT00145548·Birmingham, Alabama and 13 others

TerminatedBeta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseThis is a multicenter, prospective, randomized, double-blind, placebo-controlled trial that will enroll 1028 patients with at least moderately severe COPD over a three year period…NCT02587351·Birmingham, Alabama and 26 others

CompletedINtervention Study In overweiGHT Patients With COPDSymptoms of chronic obstructive pulmonary disease (COPD) and high body mass index (BMI) overlap.NCT02634268·Birmingham, Alabama and 38 others

TerminatedA Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPDThe purpose of this study is to determine whether ODSH, when added to conventional treatment, is more effective in treating COPD exacerbations than conventional therapy alone.NCT00457951·Orange, California and 37 others

TerminatedZileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study)Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is caused by cigarette smoking or by breathing in other lung irritants, including pollution, dust, or…NCT00493974·Birmingham, Alabama and 17 others

PreviousPage 3 of 10Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia